Does rabbit anti-thymocyte globulin dose and antiviral prophylaxis alter the risk of the development of PTLD in renal transplant population?

Ren Fail. 2020 Nov;42(1):673-674. doi: 10.1080/0886022X.2020.1792927.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antilymphocyte Serum
  • Antiviral Agents
  • Humans
  • Immunosuppressive Agents
  • Kidney Transplantation*
  • Lymphoproliferative Disorders*

Substances

  • Antilymphocyte Serum
  • Antiviral Agents
  • Immunosuppressive Agents